<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alhaj-Suliman SO</submitter><funding>NIEHS NIH HHS</funding><funding>National Institutes of Health</funding><pagination>390-399</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9670863</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite recent therapeutic advances, osteoarthritis continues to be a challenging health problem, especially in the elderly population. Opioids, which are potent analgesics, have shown an extraordinary ability to reduce intense pain in many osteoarthritic clinical trials; however, there is an increased need for a study to integrate the reported outcomes and utilize them to achieve a better understanding. Herein, efficacy and safety aspects of opioids used to manage osteoarthritic pain were assessed and compared using a model-based meta-analysis (MBMA).&lt;h4>Methods&lt;/h4>To perform the analysis, a comprehensive database consisting of pain relief compounds with information on summary-level of efficacy over time, adverse events and dropout rates was compiled from multiple sour</pubmed_abstract><journal>Current drug metabolism</journal><pubmed_title>Model-based Meta-analysis to Compare Primary Efficacy-endpoint, Efficacy-time Course, Safety, and Tolerability of Opioids Used in the Management of Osteoarthritic Pain in Humans.</pubmed_title><pmcid>PMC9670863</pmcid><funding_grant_id>P30 ES005605</funding_grant_id><funding_grant_id>P30 CA086862</funding_grant_id><pubmed_authors>Alhaj-Suliman SO</pubmed_authors><pubmed_authors>Milavetz G</pubmed_authors><pubmed_authors>Salem AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Model-based Meta-analysis to Compare Primary Efficacy-endpoint, Efficacy-time Course, Safety, and Tolerability of Opioids Used in the Management of Osteoarthritic Pain in Humans.</name><description>&lt;h4>Background&lt;/h4>Despite recent therapeutic advances, osteoarthritis continues to be a challenging health problem, especially in the elderly population. Opioids, which are potent analgesics, have shown an extraordinary ability to reduce intense pain in many osteoarthritic clinical trials; however, there is an increased need for a study to integrate the reported outcomes and utilize them to achieve a better understanding. Herein, efficacy and safety aspects of opioids used to manage osteoarthritic pain were assessed and compared using a model-based meta-analysis (MBMA).&lt;h4>Methods&lt;/h4>To perform the analysis, a comprehensive database consisting of pain relief compounds with information on summary-level of efficacy over time, adverse events and dropout rates was compiled from multiple sour</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-21T14:17:20.088Z</modification><creation>2025-04-21T14:17:20.088Z</creation></dates><accession>S-EPMC9670863</accession><cross_references><pubmed>32407270</pubmed><doi>10.2174/1389200221666200514130441</doi></cross_references></HashMap>